-
September 27: The Week in Cancer News
Adding MRI to prostate screening can help limit overdiagnosis, and breast cancer patients who smoke have a higher risk of radiotherapy-related lung cancer.
by Eric Fitzsimmons
-
September 20: The Week in Cancer News
The AACR spotlights cancer advances and challenges in new report, and the FDA approves second CDK 4/6 inhibitor to reduce risk of recurrence in early-stage breast cancer.
by Marci A. Landsmann
-
September 13: The Week in Cancer News
Mammogram findings will now include information about breast density, and youth vaping is on the decline.
by Kevin McLaughlin
-
Making Cancer a Family Affair
Instead of hiding details of her metastatic breast cancer diagnosis from her children, Michelle Audoin opened the door for clear expectations and frank conversations.
by Michelle Audoin
-
September 6: The Week in Cancer News
Asian American and Pacific Islander women experience rising breast cancer incidence, and a study finds most people diagnosed with cancer will experience cognitive symptoms.
by Thomas Celona
-
Advocacy After Loss
Following her son’s death from peripheral T-cell lymphoma, Sandy McHugh keeps his memory alive through Jake’s Dragon Foundation.
by Thomas Celona
Cancer Talk
Gaps in Survivorship Care Leave Unmet Needs After Cancer Treatment
A survey of head and neck cancer survivors reveals that many are not getting adequate survivorship care and may not even know it is available.
by Cameron Walker
Improving Communication for Deaf Cancer PatientsAfter a cancer diagnosis, people who are deaf or have hearing problems can struggle if accommodations don’t meet their communication needs.
by Eric Fitzsimmons
Is Immunotherapy Right for People Hospitalized With Advanced Cancer?Researchers find no evidence that immune checkpoint inhibitors benefit cancer patients getting inpatient care. They urge earlier consideration of palliative care.
by Kyle Bagenstose
Celebrity Cancer Stories Can Lack Important InformationNews coverage about public figures facing cancer frequently leaves out key details about the diagnosis and fails to provide background information on cancer.
by Laura Gesualdi Gilmore